Revolution Medicines (RVMD) Competitors $44.94 +0.88 (+2.00%) (As of 09:58 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RVMD vs. MRTX, KYMR, MRNA, TEVA, BGNE, GMAB, SMMT, DNA, VTRS, and RDYShould you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include Mirati Therapeutics (MRTX), Kymera Therapeutics (KYMR), Moderna (MRNA), Teva Pharmaceutical Industries (TEVA), BeiGene (BGNE), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Ginkgo Bioworks (DNA), Viatris (VTRS), and Dr. Reddy's Laboratories (RDY). These companies are all part of the "medical" sector. Revolution Medicines vs. Mirati Therapeutics Kymera Therapeutics Moderna Teva Pharmaceutical Industries BeiGene Genmab A/S Summit Therapeutics Ginkgo Bioworks Viatris Dr. Reddy's Laboratories Revolution Medicines (NASDAQ:RVMD) and Mirati Therapeutics (NASDAQ:MRTX) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability. Which has stronger valuation & earnings, RVMD or MRTX? Revolution Medicines has higher earnings, but lower revenue than Mirati Therapeutics. Revolution Medicines is trading at a lower price-to-earnings ratio than Mirati Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevolution Medicines$742K9,796.88-$436.37M-$3.75-11.75Mirati Therapeutics$12.44M331.01-$740.87M-$12.22-4.80 Is RVMD or MRTX more profitable? Revolution Medicines has a net margin of 0.00% compared to Mirati Therapeutics' net margin of -1,900.65%. Revolution Medicines' return on equity of -34.57% beat Mirati Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Revolution MedicinesN/A -34.57% -30.71% Mirati Therapeutics -1,900.65%-82.15%-67.82% Does the media prefer RVMD or MRTX? In the previous week, Revolution Medicines had 7 more articles in the media than Mirati Therapeutics. MarketBeat recorded 7 mentions for Revolution Medicines and 0 mentions for Mirati Therapeutics. Revolution Medicines' average media sentiment score of 1.06 beat Mirati Therapeutics' score of 0.00 indicating that Revolution Medicines is being referred to more favorably in the media. Company Overall Sentiment Revolution Medicines Positive Mirati Therapeutics Neutral Which has more volatility and risk, RVMD or MRTX? Revolution Medicines has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, Mirati Therapeutics has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Does the MarketBeat Community favor RVMD or MRTX? Mirati Therapeutics received 381 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 72.38% of users gave Revolution Medicines an outperform vote while only 63.56% of users gave Mirati Therapeutics an outperform vote. CompanyUnderperformOutperformRevolution MedicinesOutperform Votes7672.38% Underperform Votes2927.62% Mirati TherapeuticsOutperform Votes45763.56% Underperform Votes26236.44% Do analysts recommend RVMD or MRTX? Revolution Medicines currently has a consensus target price of $52.92, indicating a potential upside of 20.10%. Mirati Therapeutics has a consensus target price of $62.67, indicating a potential upside of 6.76%. Given Revolution Medicines' stronger consensus rating and higher possible upside, equities analysts plainly believe Revolution Medicines is more favorable than Mirati Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08Mirati Therapeutics 0 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals hold more shares of RVMD or MRTX? 94.3% of Revolution Medicines shares are held by institutional investors. 8.0% of Revolution Medicines shares are held by company insiders. Comparatively, 3.3% of Mirati Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryRevolution Medicines beats Mirati Therapeutics on 16 of the 19 factors compared between the two stocks. Ad Paradigm PressKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election Meltdown” coming this November.Click here now to see Jim’s shocking predictions for November. Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVMD vs. The Competition Export to ExcelMetricRevolution MedicinesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.27B$3.15B$5.67B$8.27BDividend YieldN/A1.95%4.94%4.06%P/E Ratio-11.7518.23146.8918.71Price / Sales9,796.88321.531,652.9270.75Price / CashN/A153.2637.1331.84Price / Book3.973.964.814.52Net Income-$436.37M-$44.34M$115.18M$225.29M7 Day Performance4.98%0.96%4.13%4.67%1 Month Performance0.94%0.67%5.43%4.59%1 Year Performance42.13%16.11%29.80%12.00% Revolution Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRTXMirati Therapeutics0.5648 of 5 stars0.56 / 5 stars$58.70flat$62.67+6.8%N/A$4.12B$12.44M-4.80587Analyst ForecastKYMRKymera Therapeutics1.1958 of 5 stars1.20 / 5 stars$46.44-1.8%$48.67+4.8%+143.3%$2.90B$88.55M-18.50170Insider SellingMRNAModerna4.4278 of 5 stars4.43 / 5 stars$69.86-3.0%$100.44+43.8%-32.9%$26.77B$4.99B-4.465,600Analyst ForecastTEVATeva Pharmaceutical Industries1.8753 of 5 stars1.88 / 5 stars$17.88+0.2%$18.89+5.6%+69.4%$20.47B$15.85B-43.6137,851BGNEBeiGene1.6063 of 5 stars1.61 / 5 stars$197.28-0.1%$241.21+22.3%-5.6%$19.12B$3.10B-26.0610,600Analyst ForecastShort Interest ↑GMABGenmab A/S4.7255 of 5 stars4.73 / 5 stars$26.20-0.9%$45.20+72.5%-29.9%$17.33B$19.02B21.832,204SMMTSummit Therapeutics1.5135 of 5 stars1.51 / 5 stars$24.56-6.3%$29.67+20.8%+1,256.9%$17.24B$700,000.00-153.50110Analyst ForecastGap UpHigh Trading VolumeDNAGinkgo Bioworks0.8009 of 5 stars0.80 / 5 stars$7.38+8.4%$1.43-80.6%+15,943.5%$16.32B$184.34M-16.771,218News CoverageGap UpHigh Trading VolumeVTRSViatris1.3052 of 5 stars1.31 / 5 stars$11.90+0.7%$12.33+3.6%+21.2%$14.07B$15.24B-198.3338,000RDYDr. Reddy's Laboratories2.3658 of 5 stars2.37 / 5 stars$78.79-0.9%$87.00+10.4%+14.7%$13.15B$288.51B19.5527,048 Related Companies and Tools Related Companies: MRTX Alternatives KYMR Alternatives MRNA Alternatives TEVA Alternatives BGNE Alternatives GMAB Alternatives SMMT Alternatives DNA Alternatives VTRS Alternatives RDY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RVMD) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVMD Stock Alerts